| Authors: |
Einsele H; Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany., Briones J; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Ciceri F; Vita-Salute San Raffaele University and Division of Transplantation, Immunology and Transplantation Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., García-Cadenas I; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Falkenburg F; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Bolaños N; Lymphoma Coalition Europe, Madrid, Spain., Heemskerk HMM; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Houot R; CHU de Rennes, Université de Rennes, INSERM U1236, Rennes, France.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Hudecek M; Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany., Locatelli F; IRCCS, Bambino Gesù Children's Hospital, Sapienza University of Rome, Rome, Italy., Morgan K; Myeloma UK, Edinburgh, UK., Morris CE; UCL Institute of Immunity and TransplantationRoyal Free Hospital, London, UK., O'Dwyer M; Department of Haematology, University Hospital Galway and National University of Ireland, Galway., Gil JS; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Sant Pau Biomedical Research Institute and Jose Carreras Leukemia Research Institute, Barcelona, Spain., van den Brink M; Memorial Sloan Kettering Cancer Center, New York, New York, USA., van de Loosdrecht AA; Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands. |
